Sebastian Arrizabalaga | Medicine and Health Sciences | Innovative Research Award

Published on by Top Teachers

Innovative Research Award

Sebastian Arrizabalaga — Oregon Health & Science University, United States

Sebastian Arrizabalaga
Affiliation Oregon Health & Science University
Country United States
Scopus ID 58650782300
Documents 3
Citations 128
h-index 2
Subject Area Ophthalmology
Event Top Teachers Awards
ORCID 0009-0007-5387-3007

Sebastian Arrizabalaga is a researcher affiliated with Oregon Health & Science University whose work encompasses experimental ophthalmology, retinal disease research, neural stem cell formulations, preclinical models, and quantitative assessment of retinal neuroprotection. His research experience combines laboratory experimentation, animal-based studies, imaging, data analysis, and research project management, supporting translational investigations relevant to retinal disorders and emerging therapeutic strategies. [1][2]

Abstract

Sebastian Arrizabalaga’s academic profile is centered on ophthalmic and retinal research conducted at Oregon Health & Science University. His research activities include evaluating neural stem cell approaches, studying retinal neuroprotection in animal models, and contributing to preclinical investigations involving retinal therapeutics. His technical background includes spectroscopy, chromatography, fluorescence imaging, confocal microscopy, fundus imaging, electroretinography, ocular procedures, and quantitative data analysis. Published work demonstrates participation in studies addressing retinal degeneration, geographic atrophy, and experimental therapeutic development. [1][3][4][5]

Keywords

Ophthalmology; retinal research; neural stem cells; retinal neuroprotection; geographic atrophy; age-related macular degeneration; preclinical research; retinal imaging; electroretinography; animal models; translational medicine; cell-based therapy.

Introduction

Sebastian Arrizabalaga’s research trajectory connects biochemical laboratory training with experimental ophthalmology. After completing a Bachelor of Arts in Chemistry at Reed College, including a thesis examining the functionality of the bacterial tellurium resistance protein TerB, he developed broader expertise in laboratory science, animal experimentation, imaging, and retinal research. His subsequent work at Oregon Health & Science University has focused on experimental approaches relevant to retinal degeneration and therapeutic development. [2][4]

Research Profile

His current research profile includes project and experiment management, preparation of clinical trial approval documentation, laboratory administration, animal colony management, experimental design, and quantitative analysis. Technical competencies encompass UV/Vis spectroscopy, biochemistry, liquid chromatography–mass spectrometry, fluorescence spectroscopy, R programming, immunofluorescence staining, confocal microscopy, optokinetic tracking, fundus imaging, electroretinography, ocular injections and implants, cryosectioning, and microtome-based tissue preparation.[1][2]

  • Retinal and ophthalmic experimental research.
  • Neural stem cell and retinal neuroprotection studies.
  • Preclinical investigation of therapies for retinal degeneration.
  • Quantitative retinal imaging and functional assessment.
  • Laboratory, animal-model, and research-project management.

Research Contributions

A principal contribution of Arrizabalaga’s research record is the quantitative evaluation of retinal neuroprotection produced by distinct human neural stem cell formulations in the Royal College of Surgeons rat model. This work provides experimental evidence for comparing cell-based approaches within a retinal degeneration model and contributes to the broader development of regenerative strategies for retinal disease.[4]

His research also includes work on improving human neural stem cell formulations for potential application to geographic atrophy, a form of advanced dry age-related macular degeneration. In related preclinical research, his collaborative publication record intersects with investigations of retinal gene editing and cell-based therapeutic safety and efficacy, reflecting a translational research pathway from experimental formulation and biological evaluation toward potential clinical applications. [3][5]

Publications

Sebastian Arrizabalaga’s highly relevant publications include a 2023 study quantifying retinal neuroprotection from two human neural stem cell formulations in the RCS rat, followed by a 2024 study addressing improvements to human neural stem cell formulations for geographic atrophy treatment. His collaborative research record also includes work on retinal genome editing using lipid nanoparticles and preclinical studies of GMP-grade retinal pigment epithelial cells for dry age-related macular degeneration, placing his contributions within active translational ophthalmology research. [4][3][5]

  1. Gautam, M., Jozic, A., Su, G. L. N., et al. (2023). Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nature Communications, 14, 6468.
  2. Arrizabalaga, S., Uchida, N., Curtis, A., Navarro, I., Stoddard, J., Tsukamoto, A., Leng, T., & Ryals, R. C. (2023). Quantification of retinal neuroprotection achieved by two different human neural stem cell formulations in the RCS rat. Investigative Ophthalmology & Visual Science, 64(8), 3841.
  3. Arrizabalaga, S., Uchida, N., Curtis, A. G., Stoddard, J., Sheffield, A., Tsukamoto, A., Leng, T., & Ryals, R. C. (2024). Improving human neural stem cell formulations for geographic atrophy treatment. Investigative Ophthalmology & Visual Science, 65(7), 1535.
  4. Surendran, H., Soundararajan, L., Patlolla, N., Stoddard, J., Arrizabalaga, S., Liu, Z., Gopal, L., Su, X., Ryals, R. C., Battu, R., & Pal, R. (2024). IND-enabling preclinical safety and efficacy studies using GMP-grade human iPSC-derived retinal pigment epithelial cells for treating dry age-related macular degeneration. Investigative Ophthalmology & Visual Science, 65(7), 716.

Research Impact

The research record is relevant to contemporary ophthalmology because retinal degeneration and geographic atrophy require improved methods for protecting or replacing vulnerable retinal cells. Sebastian Arrizabalaga’s participation in studies involving neural stem cell formulations, retinal imaging, functional testing, and preclinical safety and efficacy contributes to the experimental evidence base used to evaluate candidate regenerative and translational therapies. The listed academic profile reports 128 citations across three documents, with an h-index of 2.[1]

Award Suitability

For the Innovative Research Award associated with the Top Teachers Awards, Sebastian Arrizabalaga presents a research profile characterized by laboratory-based ophthalmic investigation, multidisciplinary collaboration, quantitative experimentation, and translational relevance. His work on retinal neuroprotection and neural stem cell formulations provides a coherent research theme connecting experimental models with potential therapeutic development. The combination of technical laboratory expertise, animal-model research, imaging, and publication activity supports consideration within an innovation-focused academic recognition framework.[1][2]

Conclusion

Sebastian Arrizabalaga’s academic record reflects developing expertise in experimental ophthalmology, retinal degeneration research, neural stem cell approaches, and preclinical therapeutic evaluation. His publications and research responsibilities demonstrate engagement with collaborative translational studies addressing retinal neuroprotection and geographic atrophy. Together with a broad technical laboratory skill set and experience managing experimental research activities, these elements form a focused profile in contemporary retinal science. [1]

References

  1. Scopus author profile for Sebastian Arrizabalaga, author identifier 58650782300. https://www.scopus.com/pages/authors/58650782300
  2. ORCID record for Sebastian Arrizabalaga, ORCID 0009-0007-5387-3007. https://orcid.org/0009-0007-5387-3007
  3. Gautam, M., Jozic, A., Su, G. L. N., et al. (2023). Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nature Communications, 14, 6468. https://doi.org/10.1038/s41467-023-42189-3
  4. Arrizabalaga, S., Uchida, N., Curtis, A., Navarro, I., Stoddard, J., Tsukamoto, A., Leng, T., & Ryals, R. C. (2023). Quantification of retinal neuroprotection achieved by two different human neural stem cell formulations in the RCS rat. Investigative Ophthalmology & Visual Science, 64(8), 3841. https://iovs.arvojournals.org/article.aspx?articleid=2788186
  5. Arrizabalaga, S., Uchida, N., Curtis, A. G., Stoddard, J., Sheffield, A., Tsukamoto, A., Leng, T., & Ryals, R. C. (2024). Improving human neural stem cell formulations for geographic atrophy treatment. Investigative Ophthalmology & Visual Science, 65(7), 1535. https://iovs.arvojournals.org/article.aspx?articleid=2796734

Alessandro Orlando | Medicine and Health Sciences | Best Researcher Award

Published on by Top Teachers

Best Researcher Award

Alessandro Orlando
Center for Trauma and Acute Care Surgery Research, HCA Healthcare,  United States
Alessandro Orlando
Affiliation Center for Trauma and Acute Care Surgery Research, HCA Healthcare
Country United States
Scopus ID 48861826200
Documents 50
Citations 548
h-index 14
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
Google Scholar ZGMH340AAAAJ

Alessandro Orlando is a clinical epidemiologist, research leader, educator, and healthcare scientist affiliated with HCA Healthcare in the United States. His work focuses on clinical epidemiology, trauma research, evidence-based medicine, predictive modeling, traumatic brain injury outcomes, and translational healthcare research. Over a professional career spanning more than sixteen years, Orlando has contributed to multicenter clinical investigations, epidemiologic methodology, trauma system research, and healthcare quality improvement initiatives. His scholarly output and leadership activities have supported the advancement of trauma care and clinical decision-making in diverse healthcare settings.[1]

Abstract

This article presents a scholarly overview of Alessandro Orlando’s academic background, professional achievements, research contributions, teaching activities, and scientific impact within medicine and health sciences. His work integrates epidemiological methods, trauma outcomes research, multicenter clinical investigations, and predictive analytics to improve patient care and healthcare decision-making. Through leadership positions in trauma research organizations and HCA Healthcare, he has contributed to the development of collaborative research infrastructures and evidence-based clinical practices.[1]

Keywords

Clinical Epidemiology; Trauma Research; Evidence-Based Medicine; Health Outcomes; Predictive Modeling; Machine Learning; Traumatic Brain Injury; Multicenter Studies; Population Health; Healthcare Research Leadership.

Introduction

Alessandro Orlando is recognized for his contributions to clinical epidemiology and trauma research. His academic preparation includes a PhD in Clinical Epidemiology from Johns Hopkins University, a Master of Public Health in Epidemiology from Virginia Commonwealth University, and a Bachelor of Science in Biology. His research career has been characterized by a sustained commitment to improving healthcare outcomes through rigorous methodological approaches, multicenter collaborations, and translational clinical investigations.[1]

His work has spanned trauma systems, neurosurgical outcomes, epidemiologic study design, healthcare analytics, and the implementation of evidence-based research frameworks within complex healthcare organizations. These activities have positioned him as a contributor to both academic and applied clinical research environments.[2]

Research Profile

As Assistant Vice President at the HCA Healthcare Center for Trauma and Acute Care Surgery Research, Orlando directs research strategy, project implementation, and multidisciplinary collaboration. His responsibilities include oversight of multicenter trauma studies, management of research portfolios, and coordination of scientific dissemination activities. He has contributed to increased scholarly productivity through abstracts, manuscripts, conference presentations, and multicenter investigations involving trauma centers across the United States.[1]

  • Clinical epidemiology and outcomes research.
  • Traumatic brain injury and neurosurgical decision support.
  • Clinical prediction model development and validation.
  • Application of machine learning in healthcare.
  • Multicenter trauma and acute care surgery research.
  • Research transparency and clinical data integrity.

Research Contributions

Orlando’s research portfolio demonstrates contributions to pulmonary complications, trauma systems, neurosurgical outcomes, emergency care pathways, and clinical intervention assessment. He has participated in large multicenter observational and interventional studies that have informed clinical practice and healthcare delivery. His work frequently emphasizes methodological rigor, real-world clinical applicability, and patient-centered outcomes.[2]

In addition to publication activities, Orlando has contributed to the development of research infrastructure through management of clinical databases and implementation of standardized systems for research governance and project oversight. Such initiatives support reproducibility, transparency, and operational efficiency in clinical research programs.[1]

Publications

Among Alessandro Orlando’s most influential publications are the multicenter POPULAR study on post-anaesthesia pulmonary complications, a randomized tramadol efficacy trial, and investigations of traumatic brain injury management and thrombectomy protocols, collectively contributing to evidence-based clinical practice and patient outcomes.[2][3][4][5]

Selected publications associated with Alessandro Orlando include highly cited contributions in respiratory medicine, urology, neurosurgery, and neurointerventional science.[2][3]

  1. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study, The Lancet Respiratory Medicine, 2019.
  2. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet, European Urology, 2012.
  3. Outcomes of a nontransfer protocol for mild traumatic brain injury with abnormal head computed tomography in a rural hospital setting, World Neurosurgery, 2014.
  4. A standardized neurointerventional thrombectomy protocol leads to faster recanalization times, Journal of NeuroInterventional Surgery, 2017.

Research Impact

The documented Scopus profile indicates a publication record of 50 indexed documents, 548 citations, and an h-index of 14, reflecting measurable influence within the biomedical research community.[1]

Beyond publication metrics, Orlando’s impact is reflected through mentoring activities, graduate-level teaching appointments at Johns Hopkins University, invited lectures on epidemiologic methods, and peer-review service for scientific journals including Frontiers in Neurology and Neurotrauma Reports. These activities contribute to the dissemination of methodological expertise and the advancement of clinical research standards.[4]

Award Suitability

Alessandro Orlando’s profile demonstrates several characteristics commonly associated with academic recognition in research excellence programs. These include sustained scholarly productivity, leadership of multicenter clinical investigations, development of research infrastructure, competitive academic funding support, peer-review service, graduate-level teaching experience, and contributions to evidence-based medicine.[1]

His integration of epidemiologic science with trauma care research, together with his commitment to collaborative healthcare innovation, aligns with the objectives of professional awards that recognize impactful research, educational contributions, and advancement of healthcare knowledge.[2]

Conclusion

Alessandro Orlando has established a multidisciplinary career at the intersection of clinical epidemiology, trauma research, and healthcare innovation. His contributions encompass scientific publication, research leadership, education, peer review, and multicenter collaboration. The available evidence indicates a sustained commitment to improving patient outcomes through evidence-based methodologies and clinically relevant research initiatives. Collectively, these accomplishments provide a substantive basis for consideration within professional research recognition programs such as the Best Researcher Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Alessandro Orlando, Author ID 48861826200. Scopus. https://www.scopus.com/pages/authors/48861826200
  2. Kirmeier, E., Eriksson, L. I., Lewald, H., Fagerlund, M. J., Hoeft, A., Hollmann, M., et al. (2019). Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. The Lancet Respiratory Medicine, 7(2), 129–140. DOI: https://doi.org/10.1016/S2213-2600(18)30294-7
  3. Bar-Or, D., Salottolo, K. M., Orlando, A., Winkler, J. V., et al. (2012). A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of acute pain. European Urology, 61(4), 736–743. DOI: https://doi.org/10.1016/j.eururo.2011.08.039
  4. Levy, A. S., Orlando, A., Salottolo, K., Mains, C. W., & Bar-Or, D. (2014). Outcomes of a nontransfer protocol for mild traumatic brain injury with abnormal head computed tomography in a rural hospital setting. World Neurosurgery, 82(1–2), e319–e323. DOI: https://doi.org/10.1016/j.wneu.2013.11.008
  5. Frei, D., McGraw, C., McCarthy, K., Whaley, M., Bellon, R. J., Loy, D., Wagner, J., et al. (2017). A standardized neurointerventional thrombectomy protocol leads to faster recanalization times. Journal of NeuroInterventional Surgery, 9(11), 1035–1040. DOI: https://doi.org/10.1136/neurintsurg-2016-012716